Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00508-020-01672-3 http://scihub22266oqcxt.onion/10.1007/s00508-020-01672-3 C7238399!7238399!32435867     free     free     free       Wien+Klin+Wochenschr 2020 ; 132 (13-14): 356-61 Nephropedia Template TP {{tp|p=32435867|t=2020. Diabetes and COVID-19: Disease?Management?People |pdf=|usr=}}{{32435867}} gab.com Text Diabetes and COVID-19: Disease Management People JO: Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=32435867 #FOAvip The current pandemic of SARS-CoV?2 coronavirus disease 2019 (COVID-19) is a particular challenge for diabetes patients. Diabetes mellitus predisposes to a particularly severe course of the disease and doubles the COVID-19 mortality risk due to pulmonary and cardiac involvement. In addition, diabetes patients often suffer from comorbidities which further worsen clinical outcomes. Glycemic control during infectious diseases is often suboptimal, and antidiabetic drugs and insulin therapy have to be adapted accordingly. On the other hand, access of diabetes patients to outpatient clinics are limited during the ongoing season urging alternative treatment options, particularly the implementation of novel telemedicine strategies. Hence, the opportunity of the COVID 19 crisis should be taken to make a significant step forward in the care for diabetes patients. Twit Text FOAVip Diabetes and COVID-19: Disease Management People ????Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=32435867 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32435867 #FOAvip English Wikipedia <ref>{{Cite pmid|32435867}}</ref> Diabetes and COVID-19: Disease?Management?People #MMPMID32435867 Peric S; Stulnig TM Wien Klin Wochenschr 2020[]; 132 (13-14): 356-61 PMID32435867show ga The current pandemic of SARS-CoV?2 coronavirus disease 2019 (COVID-19) is a particular challenge for diabetes patients. Diabetes mellitus predisposes to a particularly severe course of the disease and doubles the COVID-19 mortality risk due to pulmonary and cardiac involvement. In addition, diabetes patients often suffer from comorbidities which further worsen clinical outcomes. Glycemic control during infectious diseases is often suboptimal, and antidiabetic drugs and insulin therapy have to be adapted accordingly. On the other hand, access of diabetes patients to outpatient clinics are limited during the ongoing season urging alternative treatment options, particularly the implementation of novel telemedicine strategies. Hence, the opportunity of the COVID 19 crisis should be taken to make a significant step forward in the care for diabetes patients. äDiabetes and COVID-19: Disease?Management?People (epmc).pdf DeepDyve Pubget Overpricing